Clinical Research - Investigational Medicinal Product (IMP) Receipt and Storage

The purpose of this procedure is to ensure that deliveries of IMP for clinical research are appropriately received, processed and stored in compliance with NSW Health, SCHN, regulatory and Protocol requirements. It is acknowledged that there may be some variations in the procedure for the receipt and storage of IMP depending upon the protocol-specific requirements dictated by the Sponsor or Delegate, and in accordance with risk-assessments made by Pharmacy, as applicable. Adherence to this procedure will ensure that: * Pharmacy personnel receiving deliveries promptly identify that the delivery contains IMP for clinical research; * IMP deliveries are promptly acknowledged, processed and appropriately stored by the Senior Clinical Trials Pharmacist or Delegate.